TEVA
Teva Pharmaceutical Industries Limited American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
TEVA Stock Analysis: Buy, Sell, or Hold?
$43.65
+0.41 (+0.95%)
▲
5d:
+4.48%
30d:
+7.2%
90d:
+18.71%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (30%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$39.88 – $42.29
Position: EXTENDED
Forward P/E & Valuation
14.0x
STRETCHED
vs 11.3x historical avg
Wall Street Target
$49.44
+13.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$40.63 / $44.31
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: TEVA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When TEVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$68.86
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$42.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TEVA is currently trading at $43.65, which is considered extended relative to its 30-day fair value range of $39.88 to $42.29. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.9) compared to its historical average (11.3). At these levels, the market is pricing in 7.1% annual earnings growth.
Technical Outlook: Technically, TEVA is in a strong uptrend. The price is approaching resistance at $44.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TEVA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.44 (+13.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TEVA is in a strong uptrend. The price is approaching resistance at $44.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TEVA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $49.44 (+13.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$39.88 -
$42.29
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.5%
Trading Range & Key Levels
30-Day Trading Range
$39.88 -
$42.29
Current vs Trading Range
EXTENDED
Support Level
$40.63
Resistance Level
$44.31
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($49.44)
- BULLISH: Expecting earnings turnaround to 7.1% growth with -1.9% revenue growth
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
13.95
Wall Street Target
$49.44
(+13.3%)
Revenue Growth (YoY)
-1.9%
Earnings Growth (YoY)
-46.0%
Profit Margin
2.9%
Valuation Premium vs History
+7.1% premium
PE vs Historical
14.0 vs 11.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.1%
(market-implied from PE analysis)
1-Year Target
$46.75
(+7%)
2-Year Target
$50.07
(+15%)
3-Year Target
$53.62
(+23%)
3-Yr Target (if PE normalizes)
(PE: 14→11)
PE COMPRESSION
$43.44
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 51.3%)
$209.75
(+381%)
Base:
(SPY PE: 13.9, Growth: 51.3%)
$147.32
(+238%)
Bear:
(PE: 11.3, Growth: 51.3%)
$119.34
(+173%)
📈
Valuation based on Current Earnings
Forward PE: 12.55 | Forward EPS (Implied): $3.48
Bull Case
$52.71
(+21%)
Analyst growth 15.0%, PE expands to 13.2
Base Case
$43.65
(0%)
Market implied 0.0%, PE stable at 12.6
Bear Case
$33.39
(-24%)
Severe decline -15.0%, PE contracts to 11.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share TEVA Analysis
Share this live TEVA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TEVA)
Bullish
1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
May 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on TEVA are bullish (sentiment score +0.95) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:59 PM ET
Data refreshes hourly during market hours. Next update: 8:59 PM
Data refreshes hourly during market hours. Next update: 8:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TEVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 41 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 60 BUY |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 51 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TEVA Research Pages
